2m 2m 2m 2m 2m 2m 2m
Utah Medical Pro (UTMD)
NASDAQ
$65.20-$0.33 (-0.50%)
Price as of Jun 03, 2026 4:10 PM EDT- $211.0MMarket Cap
- 19.61%1-Year Change
- Medical Instruments & SuppliesIndustry
Utah Medical Pro (UTMD)
$65.20-$0.33 (-0.50%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 38.5M -5.83% | 40.9M -18.56% | 50.2M -3.93% | 52.3M +6.58% | |
Cost of Revenue | 16.5M -1.44% | 16.8M -16.97% | 20.2M +0.50% | 20.1M +10.74% | |
Gross Profit | 22.0M -8.87% | 24.1M -19.63% | 30.0M -6.70% | 32.2M +4.14% | |
Sales and Marketing Expense | 2.1M +7.89% | 1.9M +12.82% | 1.7M +11.81% | 1.5M +6.58% | |
Research and Development Expense | -668,000 -17.84% | -813,000 +45.18% | -560,000 +13.59% | -493,000 -6.27% | |
Depreciation and Amortization Expense | 2.1M +2.95% | 2.1M -63.72% | 5.7M -11.30% | 6.4M -3.43% | |
Total Operating Expenses | 16.5M -1.44% | 16.8M -16.97% | 20.2M +0.50% | 20.1M +10.74% | |
Operating Profit | 11.4M -16.12% | 13.6M -18.97% | 16.8M -15.22% | 19.8M +4.82% | |
Interest Income | 2.8M -16.60% | 3.4M +10.90% | 3.0M +359.30% | 661,000 +298.19% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 2.8M -16.60% | 3.4M +10.90% | 3.0M +359.30% | 661,000 +298.19% | |
Total Nonoperating Income and Expense | -120,000 -31.03% | -174,000 -167.97% | 256,000 +36.17% | 188,000 N/A | |
Income before Taxes | 14.1M -16.02% | 16.8M -16.36% | 20.1M -2.76% | 20.7M +8.38% | |
Income Taxes | 2.8M -3.55% | 2.9M -15.23% | 3.5M -17.49% | 4.2M -2.04% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 11.3M -18.65% | 13.9M -16.60% | 16.6M +0.98% | 16.5M +11.39% | |
Net Income from Continuing Operations Applicable to Common | 14.1M -16.02% | 16.8M -16.36% | 20.1M -2.76% | 20.7M +8.38% | |
Basic EPS and Net Income | 3.48 -12.12% | 3.96 -13.54% | 4.58 +1.10% | 4.53 +11.85% | |
Diluted EPS and Net Income | 3.48 -12.12% | 3.96 -13.35% | 4.57 +1.11% | 4.52 +11.88% | |
Basic Weighted Average Shares | 3.2M -7.51% | 3.5M -3.47% | 3.6M -0.22% | 3.6M -0.27% | |
Diluted Weighted Average Shares | 3.2M -7.51% | 3.5M -3.68% | 3.6M -0.16% | 3.6M -0.46% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 85.8M +3.35% | 83.0M -10.65% | 92.9M +23.74% | 75.1M +23.09% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 85.8M +3.35% | 83.0M -10.65% | 92.9M +23.74% | 75.1M +23.09% | |
Total Current Assets | 97.7M +1.47% | 96.3M -9.35% | 106.3M +18.18% | 89.9M +22.91% | |
Accumulated Depreciation | 25.3M +5.91% | 23.9M +0.86% | 23.7M +3.39% | 22.9M +0.62% | |
Property and Plant and Equipment and Net | 9.9M +1.49% | 9.8M -7.47% | 10.6M +3.20% | 10.2M -7.62% | |
Total Long-Term Assets | 9.9M +1.49% | 9.8M -7.47% | 10.6M +3.20% | 10.2M -7.62% | |
Total Assets | 122.5M +0.003% | 122.5M -9.54% | 135.5M +9.35% | 123.9M +7.12% | |
Income Taxes Payable | 337,000 -28.14% | 469,000 +45.65% | 322,000 -41.35% | 549,000 -4.85% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.6M -30.85% | 3.8M -20.23% | 4.7M -20.97% | 6.0M +59.15% | |
Total Long-Term Debt | 225,000 -20.21% | 282,000 N/A | 0 N/A | 0 N/A | |
Total Long-Term Liabilities | 674,000 N/A | 0 -100.00% | 939,000 -34.75% | 1.4M -7.16% | |
Total Liabilities | 3.3M -35.94% | 5.1M -28.47% | 7.1M -25.73% | 9.6M +13.20% | |
Retained Earnings | 128.7M -0.50% | 129.3M -6.53% | 138.3M +9.79% | 126.0M +9.27% | |
Total Stockholders Equity | 119.3M +1.57% | 117.4M -8.48% | 128.3M +12.31% | 114.3M +6.64% | |
Total Shares Outstanding | 3.2M -4.47% | 3.3M -8.13% | 3.6M +0.06% | 3.6M -0.74% | |
Cash Flow | |||||
Cash from Operating Activities | 14.7M -0.94% | 14.8M -33.44% | 22.3M +5.36% | 21.1M -0.26% | |
Capital Expenditures | 371,000 +61.30% | 230,000 -64.01% | 639,000 -21.01% | 809,000 +46.56% | |
Cash from Investing Activities | -371,000 +78.37% | -208,000 -67.45% | -639,000 -21.88% | -818,000 +48.19% | |
Dividends Paid | 4.0M -6.50% | 4.3M -0.51% | 4.3M +35.38% | 3.2M -72.41% | |
Cash from Financing Activities | -12.3M -48.24% | -23.8M +472.34% | -4.2M -24.05% | -5.5M -49.71% | |
Financials Ratio | |||||
Gross Margin | 57.12% -3.23% | 59.03% -1.31% | 59.81% -2.88% | 61.58% -2.29% | |
Operating Margin | 29.60% -10.94% | 33.23% -0.51% | 33.40% -11.75% | 37.85% -1.65% | |
Return on Assets | 9.21% -14.37% | 10.76% -16.17% | 12.83% -6.74% | 13.76% +5.75% | |
Return on Equity | 9.54% -15.55% | 11.29% -17.67% | 13.72% -7.83% | 14.88% +5.64% | |
Revenue Growth | -5.83% -68.61% | -18.56% +371.70% | -3.93% -159.81% | 6.58% -59.65% | |
Current Ratio | 37.62 +46.73% | 25.64 +13.64% | 22.56 +49.55% | 15.09 -22.77% | |
Cash Ratio | 33.01 +49.46% | 22.09 +12.01% | 19.72 +56.58% | 12.59 -22.66% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow